Scientists identify new target for Parkinson’s therapies

A master control region of a protein linked to Parkinson’s disease has been identified for the first time. The finding, made by scientists from the University of Leeds’ Astbury Centre for Structural Molecular Biology, provides a new target for the development of therapies to try and slow down or even prevent the disease. Parkinson’s affects more than 10 million people across the world, causing neurodegeneration and difficulties with movement, which increase over time.

Read the full press release on the University of Leeds website

Read A short motif in the N-terminal region of α-synuclein is critical for both aggregation and function on the Nature website